Fol. Biol. 2012, 58, 69-74
https://doi.org/10.14712/fb2012058020069
Microsatellite Polymorphism in Haem Oxygenase 1 Gene Promoter in Multiple Sclerosis
References
1. , N. G., Kappas, A. (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60, 79-127.
<https://doi.org/10.1124/pr.107.07104>
2. , V., Ernst, A., Christensen, J., Ostergaard, M., Jacobsen, B. A., Tjonneland, A., Krarup, H. B.,Vogel, U. (2010) The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med. Genet. 11, 82.
<https://doi.org/10.1186/1471-2350-11-82>
3. , C., Peeters, A., Lemos, F., Uitterlinden, A., Doxiadis, I., Claas, F., Ijzermans, J., Roodnat, J., Weimar, W. (2004) Fundamental role for HO-1 in the self-protection of renal allografts. Am. J. Transplant. 4, 811-818.
<https://doi.org/10.1111/j.1600-6143.2004.00420.x>
4. , A., Hobbs, K. G., Eguchi, A., Jeffrey, S., Smallwood, L., Pennie, C., Anderson, J., Estevez, A. G. (2009) Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen species: implications for multiple sclerosis. J. Neurochem. 109, 93-104.
<https://doi.org/10.1111/j.1471-4159.2009.05891.x>
5. , S. A., Marshall, G. D., Jr., Henninger, E. M., Sriram, S., Khan, M., Wolinsky, J. S. (1996) Interferon β-1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology 46, 1633-1638.
<https://doi.org/10.1212/WNL.46.6.1633>
6. , S., Williams, G., Yong, V. W. (1997) Microglial production of TNF-α is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferon β-1b. J. Clin. Invest. 100, 604-612.
<https://doi.org/10.1172/JCI119571>
7. , A., Emerson, M. R., LeVine, S. M. (2003) Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult. Scler. 9, 372-381.
<https://doi.org/10.1191/1352458503ms928oa>
8. , Y. H., Lin, S. J., Lin, M. W., Tsai, H. L., Kuo, S. S., Chen, J. W., Charng, M. J., Wu, T. C., Chen, L. C., Ding, Y. A., Pan, W. H., Jou, Y. S., Chau, L. Y. (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum. Genet. 111, 1-8.
<https://doi.org/10.1007/s00439-002-0769-4>
9. , S. J., Wang, Y. L., Lo, W. T., Wu, C. C., Hsieh, C. W., Huang, C. F., Lan, Y. H., Wang, C. C., Chang, D. M., Sytwu, H. K. (2010) Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162, 210-223.
<https://doi.org/10.1111/j.1365-2249.2010.04238.x>
10. , A. A., Fontoura, P., Cunha, A., Pais, T. F., Cardoso, S., Ho, P. P., Lee, L. Y., Sobel, R. A., Steinman, L., Soares, M. P. (2007) Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 117, 438-447.
<https://doi.org/10.1172/JCI28844>
11. , S., Borse, V., Colah, R. B., Ghosh, K., Mukherjee, M. B. (2011) Association of (GT)n repeats promoter polymorphism of heme oxygenase-1 gene with serum bilirubin levels in healthy Indian adults. Genet. Test. Mol. Biomarkers 15, 215-218.
<https://doi.org/10.1089/gtmb.2010.0132>
12. , J., Onclercq, R., Moisan-Coppey, M. (1991) Inhibition and enhancement of eukaryotic gene expression by potential non-B DNA sequences. Biochem. Biophys. Res. Commun. 180, 1273-1283.
<https://doi.org/10.1016/S0006-291X(05)81333-6>
13. , M., Bohmig, G. A., Schillinger, M., Regele, H., Watschinger, B., Horl, W. H., Raith, M., Mannhalter, C., Wagner, O. F. (2004a) Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation 77, 538-542.
<https://doi.org/10.1097/01.TP.0000113467.36269.F8>
14. , M., Minar, E., Wagner, O., Schillinger, M. (2004b) The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic. Biol. Med. 37, 1097-1104.
<https://doi.org/10.1016/j.freeradbiomed.2004.07.008>
15. , M., Paul, G., Kellermeier, S., Frey, I., Scholmerich, J., Falk, W., Menzel, K., Fried, M., Herfarth, H., Rogler, G. (2008) (GT)N dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course. Clin. Exp. Immunol. 153, 81-85.
<https://doi.org/10.1111/j.1365-2249.2008.03674.x>
16. , H., Kubo, H., Yamaya, M., Nakayama, K., Numasaki, M., Kobayashi, S., Suzuki, S., Shibahara, S., Sasaki, H. (2003) Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102, 1619-1621.
<https://doi.org/10.1182/blood-2002-12-3733>
17. (2010) IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun. 11, 397-405.
18. , L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., Alam, J. J., Bartoszak, D. M., Bourdette, D. N., Braiman, J., Brownscheidle, C. M., Coats, M. E., Cohan, S. L., Dougherty, D. S., Kinkel, R. P., Mass, M. K., Munschauer, F. E., 3rd, Priore, R. L., Pullicino, P. M., Scherokman, B. J., Whitham, R. H., The Multiple Sclerosis Collaborative Research Group (MSCRG) (1996) Intramuscular interferon β-1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 39, 285-294.
<https://doi.org/10.1002/ana.410390304>
19. , E., Skoura, L., Giakoustidis, D., Takoudas, D., Malisiovas, N., Daniilidis, M. (2010) Association between the heme oxygenase-1 promoter polymorphism and renal transplantation outcome in Greece. Transplant. Proc. 42, 2479-2485.
<https://doi.org/10.1016/j.transproceed.2010.05.161>
20. , A., Kovárník, T., Králík, L., Skalická, H., Horák, J., Mintz, G. S., Uhrová, J., Sonka, M., Wahle, A., Downe, R., Aschermann, M., Martásek, P., Linhart., A. (2011) Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosis. Folia Biol. (Praha) 57, 182-190.
21. , J. F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
<https://doi.org/10.1212/WNL.33.11.1444>
22. , Y., Drummond, G. S., Abraham, N. G. (1996) Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements. Biochem. Biophys. Res. Commun. 218, 759-765.
<https://doi.org/10.1006/bbrc.1996.0135>
23. , S. M., Chakrabarty, A. (2004) The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. N. Y. Acad. Sci. 1012, 252-266.
<https://doi.org/10.1196/annals.1306.021>
24. , Y., Zhu, B., Luo, L., Li, P., Paty, D. W., Cynader, M. S. (2001) Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport 12, 1841-1845.
<https://doi.org/10.1097/00001756-200107030-00016>
25. , M. D., Gibbs, P. E. (2005) 30 some years of heme oxygenase: from a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events. Biochem. Biophys. Res. Commun. 338, 568-577.
<https://doi.org/10.1016/j.bbrc.2005.08.121>
26. , S., Weltermann, A., Fritsche, R., Marsik, C., Wagner, O., Kyrle, P. A., Eichinger, S. (2008) Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism. J. Vasc. Surg. 47, 566-570.
<https://doi.org/10.1016/j.jvs.2007.09.060>
27. , L. H., Clark, E. M. (1990) d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res. 18, 1595-1601.
<https://doi.org/10.1093/nar/18.6.1595>
28. , J. R., Baranzini, S. E. (2010) Multiple sclerosis genetics – is the glass half full, or half empty? Nat. Rev. Neurol. 6, 429-437.
<https://doi.org/10.1038/nrneurol.2010.91>
29. Quesada, A., Ogi, J., Schultz, J., Handforth, A. (2011) C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cε/Nrf2 pathway. J Neurosci Res.
30. , D. W., Li, D. K. B., the UBC MS/MRI Study Group, and the IFNB Multiple Sclerosis Study Group (1993) Interferon β-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis. Neurology 43, 662-667.
<https://doi.org/10.1212/WNL.43.4.662>
31. Study Group (1998) Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis. Lancet 352, 1498-1504.
32. , M. H., Hintzen, R. Q., Polman, C. H., van Lier, R. A. (1996) Recombinant interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J. Neuroimmunol. 67, 111-118.
<https://doi.org/10.1016/0165-5728(96)00060-4>
33. , A., Nordheim, A., Wang, A. H. (1984) The chemistry and biology of left-handed Z-DNA. Annu. Rev. Biochem. 53, 791-846.
<https://doi.org/10.1146/annurev.bi.53.070184.004043>
34. , X. D., Ke, B., Uchida, Y., Ji, H., Gao, F., Zhai, Y., Busuttil, R. W., Kupiec-Weglinski, J. W. (2011) Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury. Liver Transpl. 17, 201-210.
<https://doi.org/10.1002/lt.22214>
35. , M., Exner, M., Minar, E., Mlekusch, W., Mullner, M., Mannhalter, C., Bach, F. H., Wagner, O. (2004) Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J. Am. Coll. Cardiol. 43, 950-957.
<https://doi.org/10.1016/j.jacc.2003.09.058>
36. , H. M., Song, W., Zukor, H., Hascalovici, J. R., Zeligman, D. (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J. Neurochem, 110, 469-485.
<https://doi.org/10.1111/j.1471-4159.2009.06160.x>
37. , J. S., James, I., Qiu, W., Castley, A., Christiansen, F. T., Carroll, W. M., Mastaglia, F. L., Kermode, A. G. (2010) HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. J. Neuroimmunol. 219, 109-113.
<https://doi.org/10.1016/j.jneuroim.2009.11.015>
38. , N., Yamaya, M., Okinaga, S., Nakayama, K., Sekizawa, K., Shibahara, S., Sasaki, H. (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66, 187-195.
<https://doi.org/10.1086/302729>
